These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35221589)

  • 41. Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments.
    Misiak-Galazka M; Zozula J; Rudnicka L
    Am J Clin Dermatol; 2020 Jun; 21(3):355-370. PubMed ID: 32008176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis.
    Yamamoto T
    Clin Drug Investig; 2019 Mar; 39(3):241-252. PubMed ID: 30632109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis.
    Hagforsen E; Hedstrand H; Nyberg F; Michaëlsson G
    Br J Dermatol; 2010 Sep; 163(3):572-9. PubMed ID: 20426778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection rate of pustules in palmoplantar pustulosis with dermoscopy.
    Nakanishi T; Kokubu H; Fujimoto N; Tanaka T
    J Dermatol; 2022 Feb; 49(2):299-302. PubMed ID: 34723401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence, incidence, mortality, and healthcare resource use for generalised pustular psoriasis, palmoplantar pustulosis, and plaque psoriasis in England: a population-based cohort study.
    Frysz M; Patel S; Li MOY; Griffiths CEM; Warren RB; Ashcroft DM
    Br J Dermatol; 2024 May; ():. PubMed ID: 38775029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis.
    Morales-Múnera C; Vilarrasa E; Puig L
    Br J Dermatol; 2013 Apr; 168(4):820-4. PubMed ID: 23210683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical characteristics, genetics, comorbidities and treatment of palmoplantar pustulosis: A retrospective analysis of 66 cases in a single center in Taiwan.
    Huang CM; Tsai TF
    J Dermatol; 2020 Sep; 47(9):1046-1049. PubMed ID: 32613680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The cutaneous non-neuronal cholinergic system and smoking related dermatoses: studies of the psoriasis variant palmoplantar pustulosis.
    Hagforsen E
    Life Sci; 2007 May; 80(24-25):2227-34. PubMed ID: 17341425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series.
    Xu Q; Wang X; Yang A; Wei G
    Infect Drug Resist; 2023; 16():5165-5172. PubMed ID: 37581169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Palmoplantar Pustulosis and Allergies: A Systematic Review.
    Brunasso Vernetti AMG; Puntoni M; Massone C
    Dermatol Pract Concept; 2019 Apr; 9(2):105-110. PubMed ID: 31106012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Palmoplantar pustulosis - a cross-sectional analysis in Germany.
    Wilsmann-Theis D; Jacobi A; Frambach Y; Philipp S; Weyergraf A; Schill T; Steinz K; Gerdes S; Mössner R
    Dermatol Online J; 2017 Apr; 23(4):. PubMed ID: 28541870
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies.
    Heidemeyer K; May Lee M; Cazzaniga S; Yawalkar N; Naldi L
    Psoriasis (Auckl); 2023; 13():33-58. PubMed ID: 37772169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A genome-wide meta-analysis of palmoplantar pustulosis implicates T
    Hernandez-Cordero A; Thomas L; Smail A; Lim ZQ; Saklatvala JR; Chung R; Curtis CJ; Baum P; Visvanathan S; Burden AD; Cooper HL; Dunnill G; Griffiths CEM; Levell NJ; Parslew R; Reynolds NJ; Wahie S; Warren RB; Wright A; ; Simpson M; Hveem K; Barker JN; Dand N; Løset M; Smith CH; Capon F
    J Allergy Clin Immunol; 2024 May; ():. PubMed ID: 38815935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutation analysis of IL36RN gene in Japanese patients with palmoplantar pustulosis.
    Takahashi T; Fujimoto N; Kabuto M; Nakanishi T; Tanaka T
    J Dermatol; 2017 Jan; 44(1):80-83. PubMed ID: 27542682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of anti-interleukin-17A biological agents for palmoplantar psoriasis and palmoplantar pustulosis: A network meta-analysis.
    Xia R; Diao Z; Chen D; Wang Y; Zhou C; Gao Y; Yin Z
    Int Immunopharmacol; 2024 Mar; 130():111716. PubMed ID: 38417367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.
    Yamamoto T
    Clin Pharmacol; 2021; 13():135-143. PubMed ID: 34188558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Normal and PPP-affected palmoplantar sweat gland express neuroendocrine markers chromogranins and synaptophysin differently.
    Hagforsen E; Michaëlsson G; Stridsberg M
    Arch Dermatol Res; 2010 Nov; 302(9):685-93. PubMed ID: 20640434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histological differentiation between palmoplantar pustulosis and pompholyx.
    Yoon SY; Park HS; Lee JH; Cho S
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):889-93. PubMed ID: 22691103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eosinophilic pustular folliculitis starting initially only with palmoplantar pustular lesions. Report of a case and review of the literature.
    Aoyama H; Tagami H
    Dermatology; 1992; 185(4):276-80. PubMed ID: 1477422
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.